Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Beijing Peking University WBL Biotech Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01327014
First received: March 30, 2011
Last updated: June 1, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)